1. Home
  2. IHT vs INTS Comparison

IHT vs INTS Comparison

Compare IHT & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InnSuites Hospitality Trust Shares of Beneficial Interest

IHT

InnSuites Hospitality Trust Shares of Beneficial Interest

HOLD

Current Price

$1.83

Market Cap

15.2M

Sector

Finance

ML Signal

HOLD

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$4.65

Market Cap

13.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IHT
INTS
Founded
1971
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.2M
13.2M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
IHT
INTS
Price
$1.83
$4.65
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$38.00
AVG Volume (30 Days)
294.1K
65.8K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
1.77%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,600,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.33
N/A
52 Week Low
$0.95
$0.19
52 Week High
$4.24
$8.06

Technical Indicators

Market Signals
Indicator
IHT
INTS
Relative Strength Index (RSI) 59.96 51.19
Support Level $1.34 $4.50
Resistance Level $1.90 $5.00
Average True Range (ATR) 0.19 0.26
MACD -0.01 0.01
Stochastic Oscillator 90.00 50.00

Price Performance

Historical Comparison
IHT
INTS

About IHT InnSuites Hospitality Trust Shares of Beneficial Interest

InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns interests in two hotels, operates and provides management services, and provides trademark license services, for two hotels. The Trust also holds an investment related to clean energy electricity generation technology and manages an option to acquire an investment in an independent boutique hotel reservation and hotel services business.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.

Share on Social Networks: